HS exerted treatment effects on RA by regulating 4 core targets (CSF2, IL1β, TNF, and IL6), which involved in 15 pathways such as rheumatoid arthritis, TNF signaling pathway, and cytokine-cytokine receptor interaction. The gene discussed is CSF2; the disease is rheumatoid arthritis.